Proactiveinvestors recommends
Additional Information
Market: TSX-V
Sector: Support Services
EPIC: MDG
1 year chart
digital-look imported chart image
1 day chart
digital-look imported chart image
Watchlist/Portfolio

Add to watchlist:

Only registered members can add into watchlist !

Register here !
MEDICAGO INC
www.medicago.com/en
The Company provide highly effective and affordable vaccinesbased on our proprietary Virus-Like Particles (VLPs) and manufacturing technologies.
Full MEDICAGO INC profile here
Pdf

Medicago in collaboration deal for influenza vaccines in Saudi Arabia and other territories

2nd Sep 2009, 3:31 pm Medicago in collaboration deal for influenza vaccines in Saudi Arabia and other territories

Medicago Inc (TSX-V: MDG), focused on developing vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), said it has signed a letter of intent with Saudi Arabia’s Tabuk Pharmaceuticals aimed at developing, producing and commercializing Medicago's influenza VLP-based vaccines in Saudi Arabia and other territories in the Middle East and North Africa.

Tabuk is the second largest pharmaceutical manufacturer in Saudi Arabia. The parties will collaborate to identify the interest of targeted governments and will select an optimal deal structure with the objective of establishing a commercial partnership within 12 months.

"While we continue to aggressively move forward with the development of our influenza vaccine candidates, we continue to seek out commercial opportunities that allow us to exploit our proprietary manufacturing solution," said Andy Sheldon, president and CEO of Medicago.

"With the recent approval we received to commence human clinical testing with our avian flu pandemic vaccine, we are now in a better position to explore different deal structures and markets to commercialize our vaccine candidates," added the company’s VP for business development, Frederic Ors.

No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.